Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Decreasing the Burden of Sarcopenia in Cancer Through Targeted Nutrition Intervention: A Feasibility Study
Authors not listed
University of Alberta · 2016
Abstract
This is a feasibility study to test the potential efficacy of diets of different amounts of protein and calories for patients with cancer. We hypothesize that nutritional deficits play a significant role in muscle loss and that nutritional therapy is an important first step in reversing or preventing muscle loss and maintaining/improving physical function.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2016). Decreasing the Burden of Sarcopenia in Cancer Through Targeted Nutrition Intervention: A Feasibility Study. <em>University of Alberta</em>. https://clinicaltrials.gov/study/NCT02788955
Vancouver
Anonymous. Decreasing the Burden of Sarcopenia in Cancer Through Targeted Nutrition Intervention: A Feasibility Study. University of Alberta. 2016.
BibTeX
@misc{anon2016Decrea,
title = {Decreasing the Burden of Sarcopenia in Cancer Through Targeted Nutrition Intervention: A Feasibility Study},
author = {Anonymous},
journal = {University of Alberta},
year = {2016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
SpringerPlus 2016
Open access · CC-BY
Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6
Journal of Pediatric Gastroenterology and Nutrition 1984
Citation only
Effect of Taurine Supplementation on Hepatic Function During Short-Term Parenteral Nutrition in the Premature Infant
The Affiliated Hospital of Qingdao University 2021
Open access · US-GOV
Affiliated Hospital of Qingdao University
Clinical Chemistry 1999
Open access · OA
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
CHU de Reims 2024
Open access · US-GOV
Comparison of Serum Myokine Dosages and Imaging Methods in the Evaluation of Sarcopenia in Patients With Hepatocellular Carcinoma
Oncogene 2020
Citation only